Join us on April 2, 2026 at 1:00 PM ET for this session designed for commercial, trade and channel, market access, and patient services teams who are frustrated with opaque data and are ready to move toward transparent, actionable insights.
Learning Objectives:
- Define “black box” data in specialty and rare disease and explain how it creates blind spots and undermines patient access and the ability for brands to achieve revenue forecasts.
- Describe the core elements of a transparent data foundation, including entity mastering, accurate patient matching, appropriate de-identification and/or consent management, and real‑time data availability.
- Apply a practical playbook to assess your current data environment and outline a plan to move away from opaque solutions.
